Evaluating IPFP Steroid Injections in OA - Top-Institutions - MDSpire

Evaluating IPFP Steroid Injections in OA

Randomized trial found no significant differences in pain or effusion synovitis compared with placebo, despite some favorable secondary findings.

  • By

  • Olivia Anderson

  • January 27, 2026

  • 3 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Orthopedics
    • Musculoskeletal Imaging

  • #2

    Hospital for Special Surgery (HSS)
    Hospital for Special Surgery (HSS)

    New York, NY

    Key Differentiators

    • Orthopedics
    • Rheumatology
    • Imaging Research

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Orthopedics
    • Clinical Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Orthopedics
    • Imaging

Original Source(s)

Evaluating IPFP Steroid Injections in OA

  • by Olivia Anderson

  • January 27, 2026

Related Content

The mechanism of action and therapeutic potential of macrophages in osteoporosis: from polarization balance to targeted regulation

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.

Efficacy and safety of upadacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis